Recall D-0508-2026

US Class II Ongoing · initiated 2026-04-01

Recalling firm

Wells Pharma of Houston LLC, TX

Product

fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.

Reason for recall

cGMP deviations.

← All recalls